Literature DB >> 8553671

Conversion of unresectable to resectable hepatoblastoma and long-term follow-up study.

M Reynolds1.   

Abstract

In children with hepatoblastoma, cure or a prolonged disease-free interval can only be accomplished with surgical resection of the primary tumor. Less than 50% of children with hepatoblastoma are felt to have resectable tumors at the time of diagnosis. Clinical studies have recently focused on the hypothesis that adjuvant chemotherapy can convert the unresectable tumor to a tumor that can be resected. Short-term outcomes for patients treated with adjuvant chemotherapy and subsequent resection are nearly equal to those patients treated with initial resection followed by chemotherapy. This study is a review of the current literature of the chemotherapeutic conversion of unresectable hepatoblastoma and an update on the long-term follow-up of some of these patients.

Entities:  

Mesh:

Year:  1995        PMID: 8553671     DOI: 10.1007/bf00299776

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  Does preoperative chemotherapy for hepatic tumors have an adverse effect on hepatic proliferation after delayed liver resection?

Authors:  S A Engum; R A Sidner; G A Miller; J L Grosfeld
Journal:  J Pediatr Surg       Date:  1994-08       Impact factor: 2.545

2.  Primary liver tumors in children: comparison of CT and MR imaging.

Authors:  M I Boechat; H Kangarloo; J Ortega; T Hall; S Feig; P Stanley; V Gilsanz
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

3.  Preoperative chemotherapy for hepatoblastoma in children: report of six cases.

Authors:  R J Andrassy; L P Brennan; M M Siegel; J J Weitzman; S E Siegel; P Stanley; G H Mahour
Journal:  J Pediatr Surg       Date:  1980-08       Impact factor: 2.545

4.  The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy.

Authors:  D R King; J Ortega; J Campbell; J Haas; A Ablin; D Lloyd; K Newman; J Quinn; M Krailo; J Feusner
Journal:  J Pediatr Surg       Date:  1991-09       Impact factor: 2.545

5.  Preoperative chemotherapy in hepatoblastoma.

Authors:  R M Filler; P F Ehrlich; M L Greenberg; P S Babyn
Journal:  Surgery       Date:  1991-10       Impact factor: 3.982

6.  Marked response to preoperative high-dose cis-platinum in children with unresectable hepatoblastoma.

Authors:  C T Black; A Cangir; M Choroszy; R J Andrassy
Journal:  J Pediatr Surg       Date:  1991-09       Impact factor: 2.545

7.  Primary malignant liver tumors in childhood: assessment of resectability with high-field MR and comparison with CT.

Authors:  J P Finn; M A Hall-Craggs; C Dicks-Mireaux; L Spitz; E R Howard; J Pritchard; G M Vergani
Journal:  Pediatr Radiol       Date:  1990

8.  Thirty years of experience with pediatric primary malignant liver tumors.

Authors:  M Giacomantonio; S H Ein; K Mancer; C A Stephens
Journal:  J Pediatr Surg       Date:  1984-10       Impact factor: 2.545

9.  Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival.

Authors:  E P Tagge; D U Tagge; J Reyes; A Tzakis; S Iwatsuki; T E Starzl; E S Wiener
Journal:  J Pediatr Surg       Date:  1992-03       Impact factor: 2.545

10.  Is laparatomy the first step in treatment of childhood liver tumors?--The experience from the German Cooperative Pediatric Liver Tumor Study HB-89.

Authors:  D von Schweinitz; D Bürger; H Mildenberger
Journal:  Eur J Pediatr Surg       Date:  1994-04       Impact factor: 2.191

View more
  3 in total

1.  Hepatoblastoma: a single institutional experience of 18 cases.

Authors:  Parul J Shukla; Savio G Barreto; Sajid S Qureshi; Rohini Hawaldar; Shailesh V Shrikhande; Mukta R Ramadwar; Shripad Banavali
Journal:  Pediatr Surg Int       Date:  2008-05-06       Impact factor: 1.827

2.  The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma.

Authors:  Justus Lieber; Carmen Eicher; Julia Wenz; Bettina Kirchner; Steven W Warmann; Jörg Fuchs; Sorin Armeanu-Ebinger
Journal:  BMC Cancer       Date:  2011-08-19       Impact factor: 4.430

3.  Single-walled carbon nanohorn aggregates promotes mitochondrial dysfunction-induced apoptosis in hepatoblastoma cells by targeting SIRT3.

Authors:  Bowei Li; Xiaoxun Chen; Wenbin Yang; Jingliang He; Ke He; Zhenglin Xia; Jinqian Zhang; Guoan Xiang
Journal:  Int J Oncol       Date:  2018-06-28       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.